Julia Carolin Stingl (Julia C Stingl, Julia Stingl)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Venues

Clinical pharmacology and therapeutics

Pharmaceutics

British journal of clinical pharmacology

Translational psychiatry

RWTH Aachen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RWTH Aachen Oct 01 2019

Germany

Professor :: Institute of Clinical Pharmacology

Publications

Roberto Viviani, Judith Berres, Julia Carolin Stingl
Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes. Clinical pharmacology and therapeutics (2024)
Marco Hoffmann, Julian Peter Müller, Jochen Maurer, Anne-Marie Folliot, Sabrina Yamoune, Julia Carolin Stingl
Impact of steroid hormone levels on estradiol-mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells. Basic & clinical pharmacology & toxicology (2024)
Roberto Viviani, Judith Berres, Julia Carolin Stingl
Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes. Clinical pharmacology and therapeutics 116 (3) (2024)
Jakob Sommer, Justyna Wozniak, Judith Schmitt, Jana Koch, Julia Carolin Stingl, Katja Susanne Just
Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset. Biomedicines 12 (1) (2024)
Jakob Sommer, Justyna Wozniak, Judith Schmitt, Jana Koch, Julia Carolin Stingl, Katja Susanne Just
Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset. Biomedicines 12 (1) (2024)
Julian Peter Müller, Jens Sarömba, Patrick Ziegler, Roman Tremmel, Jens Rengelshausen, Elke Schaeffeler, Katja Susanne Just, Matthias Schwab, Thomas Kraus, Julia Carolin Stingl
Nutrimetric validation of solanidine as dietary-derived CYP2D6 activity marker in vivo. Clinical pharmacology and therapeutics (2023)
Patrick Christ, Diana Dubrall, Katja Susanne Just, Britta Lewke, Maike Below, Julia Carolin Stingl, Matthias Schmid, Bernhardt Sachs
Identification and comparison of sex-specific serious adverse drug reactions in spontaneous reports and systematically collected reports (ADRED). British journal of clinical pharmacology (2023)
Prachi Desai, Anshuman Dasgupta, Alexandros Marios Sofias, Quim Peña, Robert Göstl, Ioana Slabu, Ulrich Schwaneberg, Thomas Stiehl, Wolfgang Wagner, Stefan Jockenhoevel, Julia Carolin Stingl, Rafael Kramann, Christian Trautwein, Tim H Brümmendorf, Fabian Kießling, Andreas Herrmann, Twan Lammers
Transformative Materials for Interfacial Drug Delivery. Advanced healthcare materials (2023)
Julia Carolin Stingl, Jason Radermacher, Justyna Wozniak, Roberto Viviani
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes. Pharmaceutics 14 (12) (2022)
Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Möllenhoff, Klaus Baumann, Christian Jackisch, Jan Hauke, Dimo Dietrich, Julika Borde, Tjoung-Won Park-Simon, Lars C Hanker, Katharina Prieske, Sandra Schmidt, Nana Weber-Lassalle, Esther Pohl-Rescigno, Stefan Kommoss, Frederik Marmé, Florian Heitz, Julia Carolin Stingl, Rita K Schmutzler, Philipp Harter, Eric Hahnen
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 114 (4) (2022)
Ingmar Bergs, Katja S Just, Annegret Müller, Julia Carolin Stingl, Michael Dreher
Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions. International journal of chronic obstructive pulmonary disease 17 (2022)
Julia Carolin Stingl, Jason Radermacher, Justyna Wozniak, Roberto Viviani
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes. Pharmaceutics 14 (12) (2022)
Julia Carolin Stingl, Jason Radermacher, Justyna Wozniak, Roberto Viviani
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes. Pharmaceutics 14 (12) (2022)
Jochen Fracowiak, Tatjana Huebner, Steffen Heß, Christoph Roethlein, Daria Langner, Udo Schneider, Felix Falkenberg, Catharina Scholl, Roland Linder, Julia Carolin Stingl, Britta Haenisch, Michael Steffens
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes. The pharmacogenomics journal 22 (2) (2022)
Karin Labek, Elisa Sittenberger, Valerie Kienhöfer, Luna Rabl, Irene Messina, Matthias Schurz, Julia Carolin Stingl, Katharina Luise Schneider
The gradient model of brain organization in decisions involving "empathy for pain". Cerebral cortex (New York, N.Y. : 1991) (2022)
Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Carolin Stingl, Patrick Christ, Ursula Köberle, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports. Paediatric drugs (2022)
Julia Carolin Stingl, Jason Radermacher, Justyna Wozniak, Roberto Viviani
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes. Pharmaceutics 14 (12) (2022)
Marie-Luise Herrlein, Sascha Hein, Tobias Zahn, Ines Mhedhbi, Jan Raupach, Younes Husria, Nuka Ivalu Benz, Jonathan Eisert, Daniela Ploen, Vanessa Haberger, Florian D Hastert, Lisa Henss, Barbara S Schnierle, Julia Carolin Stingl, Michael Dreher, Eberhard Hildt
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera. Viruses 14 (2) (2022)
Nersi Alaeddin, Julia Carolin Stingl, Monique M B Breteler, Folgerdiena M de Vries
Validation of self-reported medication use applying untargeted mass spectrometry-based metabolomics techniques in the Rhineland study. British journal of clinical pharmacology 88 (5) (2021)
Katja Susanne Just, Catharina Scholl, Miriam Boehme, Kathrin Kastenmüller, Johannes M Just, Markus Bleckwenn, Stefan Holdenrieder, Florian Meier, Klaus Weckbecker, Julia Carolin Stingl
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System? Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Sabrina Yamoune, Katharina Wintz, Christian Niederau, Rogerio B Craveiro, Michael Wolf, Julia Carolin Stingl
Role of cytochrome P450 2C8 genetic polymorphism and epoxygenase uncoupling in periodontal remodelling affecting orthodontic treatment. Basic & clinical pharmacology & toxicology (2021)
Julia Carolin Stingl
Antidepressant drug treatment protecting from COVID-19: one more piece in the repurposing puzzle. BJPsych open 8 (1) (2021)
Sascha Hein, Nuka Ivalu Benz, Jonathan Eisert, Marie-Luise Herrlein, Doris Oberle, Michael Dreher, Julia Carolin Stingl, Christoph Hildt, Eberhard Hildt
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines 9 (12) (2021)
Diana Dubrall, Sarah Leitzen, Irmgard Toni, Julia Carolin Stingl, M Schulz, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs. BMC pharmacology & toxicology 22 (1) (2021)
Julia Carolin Stingl, Catharina Scholl, Julia E Bosch, Roberto Viviani
Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain. Translational psychiatry 11 (1) (2021)
Arnim Johannes Gaebler, Katharina Luise Schneider, Julia Carolin Stingl, Michael Paulzen
Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status. The pharmacogenomics journal 20 (6) (2020)
Katja Susanne Just, Harald Dormann, Marlen Schurig, Miriam Böhme, Michael Steffens, Bettina Plank-Kiegele, Kristin Ettrich, Thomas Seufferlein, Ingo Gräff, Svitlana Igel, Severin Schricker, Simon U Jaeger, Matthias Schwab, Julia Carolin Stingl
The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study. British journal of clinical pharmacology 86 (11) (2020)
Roberto Viviani, Irene Messina, Julia E Bosch, Lisa Dommes, Anna Paul, Katharina L Schneider, Catharina Scholl, Julia Carolin Stingl
Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity. Translational psychiatry 10 (1) (2020)
Abdul Karim Barakat, Catharina Scholl, Michael Steffens, Kerstin Brandenburg, Marcus Ising, Susanne Lucae, Florian Holsboer, Gonzalo Laje, Ganna V Kalayda, Ulrich Jaehde, Julia Carolin Stingl
Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients. Translational psychiatry 10 (1) (2020)
Julia Carolin Stingl, Katja Susanne Just, Marlen Schurig, Miriam Böhme, Michael Steffens, Matthias Schwab, Thomas Seufferlein, Harald Dormann
Prevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals. Pharmacopsychiatry 53 (3) (2020)
Katja S Just, Richard M Turner, Vita Dolžan, Erika Cecchin, Jesse J Swen, David Gurwitz, Julia Carolin Stingl
Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts. Clinical pharmacology and therapeutics 106 (2) (2019)
Katja S Just, Harald Dormann, Miriam Böhme, Marlen Schurig, Katharina L Schneider, Michael Steffens, Sandra Dunow, Bettina Plank-Kiegele, Kristin Ettrich, Thomas Seufferlein, Ingo Gräff, Svitlana Igel, Severin Schricker, Simon U Jaeger, Matthias Schwab, Julia Carolin Stingl
Personalising drug safety-results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED). European journal of clinical pharmacology 76 (3) (2019)
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, Markus Schwarz, Andreas Conca, Gerald Zernig, Gerhard Gründer, Ekkerhard Haen, Pierre Baumann, Niels Bergemann, Hans Willi Clement, Katharina Domschke, Gabriel Eckermann, Karin Maria Egberts, Manfred Gerlach, Christine Greiner, Ursula Havemann-Reinecke, Gudrun Hefner, Renate Helmer, Ger Janssen, Eveline Jaquenoud-Sirot, Gerd Laux, Thomas Messer, Rainald Mössner, Matthias J Müller, Bruno Pfuhlmann, Peter Riederer, Alois Saria, Bernd Schoppek, Margarete Silva Gracia, Benedikt Stegmann, Werner Steimer, Julia Carolin Stingl, Manfred Uhr, Sven Ulrich, Roland Waschgler, Gabriela Zurek, Christoph Hiemke
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 19 (3) (2018)

Julia Carolin Stingl.css-eqlu8i{font-size:small;padding-left:4px;} (Julia C Stingl, Julia Stingl)

Publication Activity (10 Years)

Top Topics

Top Venues

Julia Carolin Stingl (Julia C Stingl, Julia Stingl)